CHUGAI PHARMACEUTICAL CO., LTD.
4519 | T
Overview
Corporate Details
- ISIN(s):
- N/A
- LEI:
- Country:
- Japan
- Address:
- 北区浮間五丁目５番１号
- Sector:
- Health Care
- Industry:
- Pharmaceuticals
Description
Chugai Pharmaceutical Co., Ltd. is a leading Japanese biopharmaceutical company focused on innovative drug discovery and development. With a commitment to enhancing health and quality of life, Chugai emphasizes three key growth drivers: Research and Early Development Shift (RED), digital transformation (DX), and open innovation. The company aims to allocate resources towards early-stage research and development, harnessing digital technologies to expedite the creation of novel therapies and improve efficiency throughout its value chain. Celebrating its 100th anniversary in 2025, Chugai actively collaborates with external partners to advance its pipeline, which includes therapies for various diseases, underscoring its dedication to addressing unmet medical needs.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-04-22 09:07 |
Regulatory News Service
訂正臨時報告書
|
Japanese | 39.1 KB | |
| 2025-03-28 06:43 |
Inside Information Statement
臨時報告書
|
Japanese | 27.8 KB | |
| 2025-03-27 08:12 |
Inside Information Statement
臨時報告書
|
Japanese | 39.7 KB | |
| 2025-03-27 07:57 |
Internal Control over Financial Reporting
内部統制報告書－第114期(2024/01/01－2024/12/31)
|
Japanese | 24.8 KB | |
| 2025-03-27 07:50 |
Regulatory News Service
確認書
|
Japanese | 9.6 KB | |
| 2025-03-27 07:48 |
Annual Report
有価証券報告書－第114期(2024/01/01－2024/12/31)
|
Japanese | 3.3 MB | |
| 2024-07-26 08:02 |
Regulatory News Service
確認書
|
Japanese | 9.6 KB | |
| 2024-07-26 08:01 |
Interim Report
半期報告書－第114期(2024/01/01－2024/12/31)
|
Japanese | 330.6 KB | |
| 2024-07-26 07:35 |
Regulatory News Service
確認書
|
Japanese | 9.6 KB | |
| 2024-07-26 07:30 |
Regulatory News Service
訂正有価証券報告書－第113期(2023/01/01－2023/12/31)
|
Japanese | 1.8 MB | |
| 2024-04-25 08:09 |
Regulatory News Service
確認書
|
Japanese | 9.6 KB | |
| 2024-04-25 08:07 |
Quarterly Report
四半期報告書－第114期第1四半期(2024/01/01－2024/03/31)
|
Japanese | 272.0 KB | |
| 2024-04-24 08:21 |
Regulatory News Service
確認書
|
Japanese | 9.6 KB | |
| 2024-04-24 08:11 |
Regulatory News Service
訂正有価証券報告書－第113期(2023/01/01－2023/12/31)
|
Japanese | 1.8 MB | |
| 2024-03-29 06:40 |
Inside Information Statement
臨時報告書
|
Japanese | 29.3 KB |
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
ABIVAX | France | ABVX | |
|
Addex Therapeutics Ltd | Switzerland | ADXN | |
|
AegirBio AB | Sweden | AEGIR | |
|
AGRONOMICS LIMITED | Isle of Man | ANIC | |
|
AIREA PLC | United Kingdom | AIEA | |
|
Alkaloid AD | North Macedonia | ALK | |
| Alma Yesodot Ltd. | Israel | KVSR | ||
|
Amphastar Pharmaceuticals Inc. | United States of America | AMPH | |
| Ananda Pharma Plc | United Kingdom | N/A | ||
|
AnGes, Inc. | Japan | 4563 |